Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Phibro Animal Health Corporation(PAHC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PAHC
10/09/2026: PAHC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Phibro Animal Health Corporation is a global player in the animal health and mineral nutrition markets, serving the livestock and companion animal sectors. Its strengths lie in a diversified portfolio of specialty additives and a long-standing presence in the agricultural supply chain. The company’s primary investment story centers on its potential to expand into high-margin companion animal products while maintaining steady cash flows from livestock segments. However, investors must monitor regulatory risks regarding antibiotic use and competition from significantly larger animal health conglomerates. This stock may suit value-oriented or income-focused investors who prioritize steady, albeit moderate, growth and value long-term stability over short-term volatility.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers steady, moderate growth rather than the high-growth trajectory sought by aggressive growth investors. |
| Momentum investor | Weak fit | The stock typically lacks the explosive price momentum often associated with this strategy. |
| Value investor | Strong fit | Phibro is often priced reasonably relative to its earnings, appealing to investors seeking steady, cash-flow-positive businesses. |
| Dividend investor | Strong fit while signal remains positive | Consistent dividend payments make it a potential candidate for income-focused portfolios. |
| Low-risk investor | Mixed fit | While established, the company is exposed to cyclical livestock industry risks and regulatory volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can be sensitive to commodity cycles and sector-specific news. |
| Valuation risk | Low | The company typically trades at modest multiples, limiting extreme downside from valuation compression. |
| Competition risk (Animal Health Conglomerates) | High | Large competitors like ZTS and ELAN have massive R&D resources that can pressure Phibro's market share. |
| Business quality | Medium | The company has strong niche positions but lacks the broader defensive moat of its largest peers. |
| Dividend income | Medium | Dividends are stable but not necessarily high-yield compared to alternative income investments. |
| Execution risk | Medium | Success depends on ongoing R&D and navigating complex global regulatory approval processes. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 101.51% | Avg. Invested days 45 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.52B USD | Price to earnings Ratio 15.39 | 1Y Target Price 44 |
Price to earnings Ratio 15.39 | 1Y Target Price 44 | ||
Volume (30-day avg) 249.4K shares | Beta 0.42 | 52 Weeks Range 28.04 - 59.64 | Updated Date 10/09/2026 |
52 Weeks Range 28.04 - 59.64 | Updated Date 10/09/2026 | ||
Dividends yield (FY) 1.27% | Basic EPS (TTM) 2.43 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Animal Health | Vaccines, medicated feed additives, and specialty health products for livestock. | This is the primary revenue engine, relying on livestock farmers globally needing health products. |
| Mineral Nutrition | Trace minerals and nutritional ingredients. | Provides stable, recurring revenue from farmers focusing on animal health and yield optimization. |
| Performance Products | Specialty chemicals for non-animal applications. | A smaller, diversified segment providing exposure to industrial and personal care markets. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 15.39 | Forward PE 13.83 | Enterprise Value 2.09B | Price to Sales(TTM) 1 |
Enterprise Value 2.09B | Price to Sales(TTM) 1 | ||
Enterprise Value to Revenue 1.38 | Enterprise Value to EBITDA 8.98 | Shares Outstanding 21.11M | Shares Floating 20.91M |
Shares Outstanding 21.11M | Shares Floating 20.91M | ||
Percent Insiders 0.88 | Percent Institutions 103.98 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.